姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Ren,Zheng-Wei | Chairman | 21.91% | |
Ren,Pei-Qi | Director | 1.16% | |
Su,Yan-Ren | Director | 0.78% | |
Zhong,Jin-Feng | Director | 0.00% | |
Lin,Ming-Zhang | Independent Director | 0.40% | |
Lin,Shi-Xun | Independent Director | 0.00% | |
Chen,Hong-Yuan | Independent Director | 0.00% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 115,478 | 285,473 | 257,396 |
Operating cost | 102,141 | 238,701 | 190,249 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 13,337 | 46,772 | 67,147 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 13,337 | 46,772 | 67,147 |
Operating expenses | 20,340 | 74,704 | 69,259 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -7,003 | -27,932 | -2,112 |
Non-operating income and expenses | 1,144 | 3,555 | 32,334 |
Net profit (loss) before tax | -5,859 | -24,377 | 30,222 |
Income tax expense (benefits) | 1 | -4,601 | 10,681 |
Net profit (loss) of ongoing business for the current period | -5,860 | -19,776 | 19,541 |
Profit (loss) of closed units | 0 | - | - |
Profit (loss) of non-jointly controlled equity before merger | 0 | - | - |
Net profit (loss) for the current period | -5,860 | -19,776 | 19,541 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -5,860 | -19,776 | 19,541 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | -1 | 1 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 127,864 | 186,834 | 202,007 |
Non-current asset | 64,773 | 65,933 | 71,507 |
Total asset | 192,637 | 252,767 | 273,514 |
Current liability | 78,059 | 131,344 | 119,471 |
Non-current liability | 9,218 | 10,203 | 10,947 |
Total liability | 87,277 | 141,547 | 130,418 |
share capital | 121,000 | 121,000 | 121,000 |
Equity - secruity token | - | - | - |
capital reserve | 2 | 2 | 2 |
retained earning | -15,642 | -9,782 | 22,094 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 105,360 | 111,220 | 143,096 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 8 | 9 | 11 |